ATE445637T1 - Synthese von peptid t-20 mit peptidfragmentzwischenprodukten - Google Patents
Synthese von peptid t-20 mit peptidfragmentzwischenproduktenInfo
- Publication number
- ATE445637T1 ATE445637T1 AT05823175T AT05823175T ATE445637T1 AT E445637 T1 ATE445637 T1 AT E445637T1 AT 05823175 T AT05823175 T AT 05823175T AT 05823175 T AT05823175 T AT 05823175T AT E445637 T1 ATE445637 T1 AT E445637T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- synthesis
- intermediate products
- fragment intermediate
- peptide fragment
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 108010033276 Peptide Fragments Proteins 0.000 title 1
- 102000007079 Peptide Fragments Human genes 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64082204P | 2004-12-30 | 2004-12-30 | |
PCT/EP2005/013852 WO2006069727A2 (en) | 2004-12-30 | 2005-12-22 | Synthesis of peptide t-20 using peptide intermediate fragments |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE445637T1 true ATE445637T1 (de) | 2009-10-15 |
Family
ID=36520126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05823175T ATE445637T1 (de) | 2004-12-30 | 2005-12-22 | Synthese von peptid t-20 mit peptidfragmentzwischenprodukten |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070213504A1 (de) |
EP (1) | EP1960423B1 (de) |
JP (1) | JP4886701B2 (de) |
KR (1) | KR20070111463A (de) |
CN (1) | CN101133078B (de) |
AT (1) | ATE445637T1 (de) |
CA (1) | CA2593864C (de) |
DE (1) | DE602005017206D1 (de) |
ES (1) | ES2332142T3 (de) |
IL (1) | IL184081A (de) |
MX (1) | MX2007007916A (de) |
WO (1) | WO2006069727A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2205624B1 (de) * | 2007-10-27 | 2016-09-07 | Corden Pharma Colorado, Inc. | Synthese eines insulinotropen peptids mithilfe von feststoff- und flüssigphasenkombinationsverfahren |
EP2222695A2 (de) * | 2007-12-11 | 2010-09-01 | F. Hoffmann-La Roche AG | Synthese eines insulinotropen peptids mithilfe von feststoff- und flüssigphasenkombinationsverfahren |
CN102680463B (zh) * | 2012-05-17 | 2014-07-02 | 新疆天康畜牧生物技术股份有限公司 | 一种改进的茚三酮对固相多肽合成的检测方法 |
CN110372781B (zh) * | 2019-07-29 | 2021-11-16 | 深圳佳肽生物科技有限公司 | 恩夫韦肽的制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817758A (en) * | 1995-06-07 | 1998-10-06 | Terrapin Technologies, Inc. | P-nitrobenzyl side-chain protection for solid-phase synthesis |
US6281331B1 (en) * | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
US20040209999A1 (en) * | 2002-08-16 | 2004-10-21 | Bohling James Charles | Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto |
AU2004200485A1 (en) * | 2003-02-25 | 2004-09-09 | Rohm And Haas Company | Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto |
-
2005
- 2005-12-22 KR KR1020077017402A patent/KR20070111463A/ko not_active Application Discontinuation
- 2005-12-22 WO PCT/EP2005/013852 patent/WO2006069727A2/en active Application Filing
- 2005-12-22 JP JP2007548731A patent/JP4886701B2/ja not_active Expired - Fee Related
- 2005-12-22 EP EP05823175A patent/EP1960423B1/de not_active Not-in-force
- 2005-12-22 DE DE602005017206T patent/DE602005017206D1/de active Active
- 2005-12-22 CA CA2593864A patent/CA2593864C/en not_active Expired - Fee Related
- 2005-12-22 AT AT05823175T patent/ATE445637T1/de not_active IP Right Cessation
- 2005-12-22 ES ES05823175T patent/ES2332142T3/es active Active
- 2005-12-22 CN CN2005800488508A patent/CN101133078B/zh not_active Expired - Fee Related
- 2005-12-22 MX MX2007007916A patent/MX2007007916A/es not_active Application Discontinuation
- 2005-12-30 US US11/322,990 patent/US20070213504A1/en not_active Abandoned
-
2007
- 2007-06-20 IL IL184081A patent/IL184081A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2593864C (en) | 2013-08-06 |
WO2006069727A3 (en) | 2006-08-10 |
CN101133078B (zh) | 2011-07-27 |
EP1960423A2 (de) | 2008-08-27 |
DE602005017206D1 (de) | 2009-11-26 |
EP1960423B1 (de) | 2009-10-14 |
JP2008526697A (ja) | 2008-07-24 |
IL184081A0 (en) | 2007-10-31 |
CN101133078A (zh) | 2008-02-27 |
IL184081A (en) | 2010-12-30 |
JP4886701B2 (ja) | 2012-02-29 |
MX2007007916A (es) | 2007-08-14 |
US20070213504A1 (en) | 2007-09-13 |
WO2006069727A2 (en) | 2006-07-06 |
ES2332142T3 (es) | 2010-01-27 |
KR20070111463A (ko) | 2007-11-21 |
CA2593864A1 (en) | 2006-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2533874T3 (es) | Armazón proteico | |
DE602005008996D1 (de) | Radiofluorierte peptide | |
ATE507235T1 (de) | Synthese von glucagon-ähnlichen peptiden | |
WO2006027705A3 (en) | Synthesis of triethylenetetramines | |
IL206497A (en) | Isolated nucleic acid encoding the carboxylic end of a conxin protein bound to a cellular carrier | |
GB2433936A (en) | Therapeutic peptides comprising sequences derived from CDR2 or CDR3 of trem-1 and uses thereof to inhibit sepsis | |
AR076977A1 (es) | Proteinas precursoras repetitivas autoensambladas | |
BRPI0718996A2 (pt) | Síntese de peptídio em fase sólida com boc e fmoc. | |
CL2008003660A1 (es) | Metodo para obtener un peptido insulinotropico tipo glp-1 mediante la union de fragmentos del mismo ya sea en solucion o en fase solida; y peptidos intermediarios aqui empleados. | |
ATE425179T1 (de) | Reinigung von glykopeptiden | |
ATE445637T1 (de) | Synthese von peptid t-20 mit peptidfragmentzwischenprodukten | |
IL184080A (en) | Synthesis of peptide t-20 using peptide intermediate fragments | |
ATE439371T1 (de) | Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten | |
WO2007078633A8 (en) | Bacteriocin inducer peptides | |
ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
EA201291416A1 (ru) | Пептиды, связывающиеся с рецептором инсулиноподобного фактора роста 1 | |
ATE512159T1 (de) | Cyclodipeptidsynthetasen und ihre verwendung zur synthese von cyclo(leu-leu)cyclodipeptid | |
DK1480998T3 (da) | Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger | |
ATE448240T1 (de) | Peptidsynthese von alpha-helices auf peg-harz | |
DE60326128D1 (de) | Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen | |
ATE381572T1 (de) | Synthese von spongosin | |
DE602006008751D1 (de) | Synthese von proteaseinhibitorvorstufen | |
DE60306636D1 (de) | Wachstumhormonsekretionsförderer | |
WO2011068538A3 (en) | General method for generating ultra-high affinity binding proteins | |
EA200701031A1 (ru) | Молекулы, способствующие гематопоэзу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |